tumor free survival 5 years [clinicaltrials_resource:22dc798d006ce5e7c47777636fe48338]

tumor free survival 5 years [clinicaltrials_resource:22dc798d006ce5e7c47777636fe48338]

two cycles of 177Lutetium radioreceptor therapy within two month
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:22dc798d006ce5e7c47777636fe48338
clinicaltrials:NCT01201096
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

tumor free survival 5 years [clinicaltrials_resource:22dc798d006ce5e7c47777636fe48338]

two cycles of 177Lutetium radioreceptor therapy within two month
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:22dc798d006ce5e7c47777636fe48338
Bio2RDF identifier
22dc798d006ce5e7c47777636fe48338
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:22dc798d006ce5e7c47777636fe48338
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
description
two cycles of 177Lutetium radioreceptor therapy within two month
identifier
clinicaltrials_resource:22dc798d006ce5e7c47777636fe48338
title
tumor free survival 5 years
@en
inDataset
type
label
tumor free survival 5 years [clinicaltrials_resource:22dc798d006ce5e7c47777636fe48338]
@en